POPDC proteins as potential novel therapeutic targets in cancer

Johanna N Amunjela, Steven J Tucker

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Popeye domain-containing (POPDC) proteins are a novel class of cAMP-binding molecules that affect cancer cell behaviour and correlate with poor clinical outcomes. They are encoded by the POPDC genes POPDC1, POPDC2, and POPDC3. The deletion of POPDC genes and the suppression of POPDC proteins correlate with enhanced cancer cell proliferation, migration, invasion, metastasis, drug resistance, and poor patient survival in various human cancers. Overexpression of POPDC proteins inhibits cancer cell migration and invasion in vitro. POPDC proteins present promising anticancer therapeutic targets and here we review their roles in promoting cancer progression and highlight their potential as anticancer therapeutic targets.
Original languageEnglish
Pages (from-to)1920-1927
Number of pages8
JournalDrug Discovery Today
Volume21
Issue number12
Early online date22 Jul 2016
DOIs
Publication statusPublished - Dec 2016

Fingerprint

Neoplasms
Cell Movement
Therapeutics
Drug Resistance
Genes
Cell Proliferation
Protein Domains
Neoplasm Metastasis
Survival
In Vitro Techniques

Cite this

POPDC proteins as potential novel therapeutic targets in cancer. / Amunjela, Johanna N; Tucker, Steven J.

In: Drug Discovery Today, Vol. 21, No. 12, 12.2016, p. 1920-1927.

Research output: Contribution to journalArticle

Amunjela, Johanna N ; Tucker, Steven J. / POPDC proteins as potential novel therapeutic targets in cancer. In: Drug Discovery Today. 2016 ; Vol. 21, No. 12. pp. 1920-1927.
@article{daef6cff02784b65ad5a79981edd6bfd,
title = "POPDC proteins as potential novel therapeutic targets in cancer",
abstract = "Popeye domain-containing (POPDC) proteins are a novel class of cAMP-binding molecules that affect cancer cell behaviour and correlate with poor clinical outcomes. They are encoded by the POPDC genes POPDC1, POPDC2, and POPDC3. The deletion of POPDC genes and the suppression of POPDC proteins correlate with enhanced cancer cell proliferation, migration, invasion, metastasis, drug resistance, and poor patient survival in various human cancers. Overexpression of POPDC proteins inhibits cancer cell migration and invasion in vitro. POPDC proteins present promising anticancer therapeutic targets and here we review their roles in promoting cancer progression and highlight their potential as anticancer therapeutic targets.",
author = "Amunjela, {Johanna N} and Tucker, {Steven J}",
note = "We would like to thank the University of Aberdeen College of Life Sciences and Medicine for funding our research.",
year = "2016",
month = "12",
doi = "10.1016/j.drudis.2016.07.011",
language = "English",
volume = "21",
pages = "1920--1927",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - POPDC proteins as potential novel therapeutic targets in cancer

AU - Amunjela, Johanna N

AU - Tucker, Steven J

N1 - We would like to thank the University of Aberdeen College of Life Sciences and Medicine for funding our research.

PY - 2016/12

Y1 - 2016/12

N2 - Popeye domain-containing (POPDC) proteins are a novel class of cAMP-binding molecules that affect cancer cell behaviour and correlate with poor clinical outcomes. They are encoded by the POPDC genes POPDC1, POPDC2, and POPDC3. The deletion of POPDC genes and the suppression of POPDC proteins correlate with enhanced cancer cell proliferation, migration, invasion, metastasis, drug resistance, and poor patient survival in various human cancers. Overexpression of POPDC proteins inhibits cancer cell migration and invasion in vitro. POPDC proteins present promising anticancer therapeutic targets and here we review their roles in promoting cancer progression and highlight their potential as anticancer therapeutic targets.

AB - Popeye domain-containing (POPDC) proteins are a novel class of cAMP-binding molecules that affect cancer cell behaviour and correlate with poor clinical outcomes. They are encoded by the POPDC genes POPDC1, POPDC2, and POPDC3. The deletion of POPDC genes and the suppression of POPDC proteins correlate with enhanced cancer cell proliferation, migration, invasion, metastasis, drug resistance, and poor patient survival in various human cancers. Overexpression of POPDC proteins inhibits cancer cell migration and invasion in vitro. POPDC proteins present promising anticancer therapeutic targets and here we review their roles in promoting cancer progression and highlight their potential as anticancer therapeutic targets.

U2 - 10.1016/j.drudis.2016.07.011

DO - 10.1016/j.drudis.2016.07.011

M3 - Article

VL - 21

SP - 1920

EP - 1927

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 12

ER -